Ocugen (FRA:2H51) Machinery, Furniture, Equipment : €3.37 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Ocugen Machinery, Furniture, Equipment?

Ocugen's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was €3.37 Mil.

Ocugen's quarterly Machinery, Furniture, Equipment increased from Sep. 2024 (€3.25 Mil) to Dec. 2024 (€3.46 Mil) but then declined from Dec. 2024 (€3.46 Mil) to Mar. 2025 (€3.37 Mil).

Ocugen's annual Machinery, Furniture, Equipment declined from Dec. 2022 (€1.91 Mil) to Dec. 2023 (€1.74 Mil) but then increased from Dec. 2023 (€1.74 Mil) to Dec. 2024 (€3.46 Mil).

Ocugen Machinery, Furniture, Equipment Historical Data

The historical data trend for Ocugen's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen Machinery, Furniture, Equipment Chart

Ocugen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

0.51

1.01

1.91

1.74

3.46

Ocugen Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															1.75	3.08	3.25	3.46	3.37

Ocugen Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Ocugen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (FRA:2H51) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

OCGN:USA OCGN:Mexico 2H51:Germany 2H51:Germany

Address

11 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.ocugen.com

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Headlines

No Headlines